A collection of feature articles, study abstracts, and other resources all focused on iron deficiency and heart failure.
IRONMAN trial highlighted that anemia severity and TSAT < 20% are key indicators for identifying patients with heart failure who may benefit from intravenous iron therapy.
Recent studies highlight the growing interest surrounding the use of IV iron for patients with HFrEF and iron deficiency.
Among the landscape of HF, comorbidities such as anemia and iron deficiency have garnered attention for their potential impact on patient outcomes.
The following is a summary of “Effect of iron deficiency on RV function in acute decompensated...
The administration of ferric carboxymaltose in patients with decompensated acute HF and iron...
PW QUIZ
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
